BRCA‐1, which contributes to HR in S/G2‐phase cells and NHEJ in G1‐phase cells, negatively regulates carcinogenesis, especially in breast cancer and ovarian cancer.44 This evidence concerns the gene BRCA1 and ovarian carcinoma.